GENEVAD, SE / ACCESS Newswire / August 14, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...
In a news release, NRx Pharmaceuticals said that it has submitted an application for EUA to the FDA for the use of its drug Zyesami. The company developed it for patients with Covid-19 who are at ...
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
GENEVA, SWITZERLAND / ACCESSWIRE / November 11, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...
Looking for the most shorted stocks?
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Swiss biopharmaceutical company Relief Therapeutics (OTCMKTS:RLFTF) is up 31% today after its U.S. commercial partner NRx Pharmaceuticals (NASDAQ:NRXP) filed for emergency-use authorization with the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results